The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
BACKGROUND: At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the